Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Riviere

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Annals of Surgical Oncology|April 19, 2020
ASO Author Reflections: Prognostic Utility of Pre- and Postoperative Circulating Tumor DNA Liquid Biopsies in Patients with Peritoneal MetastasesJoel M Baumgartner, Paul Riviere, Razelle Kurzrock
JAMA Oncology|May 8, 2020
Managing Cancer Pain During the Opioid Epidemic-Balancing Caution and CompassionLucas K Vitzthum, Paul Riviere, James D Murphy
Journal of the National Cancer Institute|February 1, 2025
Response to OleribePaul Riviere, James D Murphy, Lucas K Vitzthum
JCO Precision Oncology|September 14, 2020
Total Number of Alterations in Liquid Biopsies Is an Independent Predictor of Survival in Patients With Advanced CancersPeter Vu, Yulian Khagi, Paul Riviere, et al.
Cancers|December 9, 2023
Adjuvant Radiation in Resectable Node-Positive Merkel Cell Carcinoma in the Immunotherapy Era: Implications for Future and Ongoing TrialsPaul Riviere, Anna M Dornisch, Parag Sanghvi, et al.
Journal of Pain and Symptom Management|June 11, 2023
Retrospective Review of Follow-up Strategies for Patients Receiving Palliative RadiotherapyVeronica Q Lin, Paul Riviere, James D Murphy, et al.
American Journal of Clinical Oncology|January 12, 2022
Temporal Trends and Predictors of Opioid Use Among Older Patients With CancerMia Salans, Paul Riviere, Lucas K Vitzthum, et al.
JAAD International|July 26, 2022
Comorbid immunosuppression in Merkel cell carcinoma: A retrospective database studyPaul Riviere, Danielle Brazel, Khodayar Goshtasbi, et al.
Oncoimmunology|September 14, 2020
Tumor mutational burden is not predictive of cytotoxic chemotherapy responseMina Nikanjam, Paul Riviere, Aaron Goodman, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2020
Cost-Effectiveness Analysis of Stereotactic Ablative Radiation Therapy in Patients With Oligometastatic CancerAbhishek Kumar, Christopher Straka, Patrick T Courtney, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Annals of Surgical Oncology|April 19, 2020
ASO Author Reflections: Prognostic Utility of Pre- and Postoperative Circulating Tumor DNA Liquid Biopsies in Patients with Peritoneal MetastasesJoel M Baumgartner, Paul Riviere, Razelle Kurzrock
JAMA Oncology|May 8, 2020
Managing Cancer Pain During the Opioid Epidemic-Balancing Caution and CompassionLucas K Vitzthum, Paul Riviere, James D Murphy
Journal of the National Cancer Institute|February 1, 2025
Response to OleribePaul Riviere, James D Murphy, Lucas K Vitzthum
JCO Precision Oncology|September 14, 2020
Total Number of Alterations in Liquid Biopsies Is an Independent Predictor of Survival in Patients With Advanced CancersPeter Vu, Yulian Khagi, Paul Riviere, et al.
Cancers|December 9, 2023
Adjuvant Radiation in Resectable Node-Positive Merkel Cell Carcinoma in the Immunotherapy Era: Implications for Future and Ongoing TrialsPaul Riviere, Anna M Dornisch, Parag Sanghvi, et al.
Journal of Pain and Symptom Management|June 11, 2023
Retrospective Review of Follow-up Strategies for Patients Receiving Palliative RadiotherapyVeronica Q Lin, Paul Riviere, James D Murphy, et al.
American Journal of Clinical Oncology|January 12, 2022
Temporal Trends and Predictors of Opioid Use Among Older Patients With CancerMia Salans, Paul Riviere, Lucas K Vitzthum, et al.
JAAD International|July 26, 2022
Comorbid immunosuppression in Merkel cell carcinoma: A retrospective database studyPaul Riviere, Danielle Brazel, Khodayar Goshtasbi, et al.
Oncoimmunology|September 14, 2020
Tumor mutational burden is not predictive of cytotoxic chemotherapy responseMina Nikanjam, Paul Riviere, Aaron Goodman, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2020
Cost-Effectiveness Analysis of Stereotactic Ablative Radiation Therapy in Patients With Oligometastatic CancerAbhishek Kumar, Christopher Straka, Patrick T Courtney, et al.
Pageof 6